Retail stakes proved costly for Demant during first coronavirus lockdown
Hearing aid company Demant's business model has emphasized buying retail firms and other companies, as well as owning retail stores. During the first Covid-19 lock-down this was a costly affair.
BY ALBERT RØNNING-ANDERSSON, TRANSLATED BY NIELSINE NIELSEN
"Closed due to Covid-19".
Messages like this have appeared in the shop windows of Demant's 2,500 clinics in 18 countries around the world, where hearing-impaired patients would normally have gone to adjust hearing aids or buy new devices.
Bavarian Nordic’s smallpox vaccine, Jynneos, hasn’t yet been approved for monkeypox in Europe, a fact that hasn’t stopped countries there from lining up to secure vaccine supplies in light of the recent outbreak.
A low value assessment, a high structural value, and no dominant shareholders make GN Group a reasonable investment case for international private equity firms and industrial players. But just how likely is it? Analysts reveal their best bets for what a GN acquisition could look like.